The Ministry of Health and Prevention (MOHAP) of the United Arab Emirates has announced the development of a new digital platform “Tatmeen”, a track-and-trace platform for the country’s healthcare sector to fortify and secure healthcare supply chains. As a first for the region, “Tatmeen” will use advanced serialization and tracing technology to track medicines from production to end-use. MOHAP is partnering with EVOTEQ, a UAE based digital solution provider for the development and operations of the platform.
The solution will enable tracking of pharma products through their journey in the supply chain on a single integrated digital platform, promoting trust and transparency in the healthcare industry from end-to-end. It will also help MOHAP tackle challenges such as counterfeit or expired medical supplies and unauthorized products.
Regulatory authorities will be able to use Tatmeen to assist them in their mission to prevent the entry of counterfeit or unauthorized medicines into the country using a web portal and mobile. The platform will also empower consumers to be able to verify products at the point of purchase allowing them to avoid unapproved and counterfeit medicine, providing visibility on product origins, safety, and validity through a unique, serialised 2-D matrix bar code.
HE Awad Saghir Al Ketbi, Assistant Undersecretary of the Support Services for MOHAP mentioned that Tatmeen is an evidence of the UAE’s progress in creating and embracing new technologies that contribute to a smarter society, it will be based on an advanced track and trace product for Pharmaceuticals which will serve as the core serialization repository. With the use of advanced technology and standards, the solution will ensure greater accountability from participants in the healthcare supply chain and accelerate our ability to trace drugs at every point of the supply chain.
Mrs. Mubaraka M. Ibrahim Director of Information Technology for MOHAP noted that Tatmeen will be built using best of breed technology components which will enable speed of transaction processing, agility to change and adapt to new scenarios and deliver a highly secure mechanism to trace drugs from point of manufacture to the point of consumption. The platform will be designed considering the future needs of the UAE healthcare market and integrated with the existing services provided by MOHAP.
Jihad Tayara, CEO of EVOTEQ commented on the occasion saying: “We are proud to be working with MOHAP to fulfil their ambitions of establishing a smart healthcare system in the country, offering our expertise and our established Smart Track solution to solve critical challenges and facilitate a seamless, efficient means of information exchange between everyone involved. This project is an important aspect of EVOTEQ’s commitment to developing large-scale solutions and platforms that lead to healthier, happier, digitally empowered societies.”